Pharmacy
Beginning February 1, 2022, the following changes will be made to Outpatient Pharmacy Clinical Coverage Criteria and the accompanying prior authorization request forms:
- Cystic Fibrosis
- Minimum age for Trikafta changed from 12 years to 6 years, or greater. Updated criteria and form.
- Hepatitis C
- Clarified duration of therapy for Mavyret for treatment experienced genotype 1 & 3 patients, includes patients with liver and kidney transplant. Minimum age for Mavyret changed from 12 to 3 years of age; minimum weight requirement removed; added Mavyret pellet packs. Updated criteria and forms for Mavyret.
- Minimum age for Epclusa changed from 6 to 3 years of age; minimum weight requirement removed; added Epclusa pellet packs. Updated criteria and forms for Epclusa and generic Epclusa, Sofosbuvir-Velpatasvir.
- Opioid Analgesics
- Added generic Hysingla ER. Updated criteria with no change to form.
- PCSK9 Inhibitors
- Added Homozygous Familial Hypercholesterolemia (HoFH) for Praluent. Updated criteria and form.
- Zolgensma
- Added exemption from providing (CHOP-INTEND) score or HINE score for infants initiating treatment based on Newborn Screening results indicating baby has SMA. Updated criteria and form.
Carolina Complete Health covers most prescription medications. Some prescriptions require prior authorization and may have limitations based on age or the amount of medicine prescribed. Carolina Complete Health also covers certain over-the-counter medications with a prescription from a Carolina Complete Health provider.
What Pharmacy Benefits are covered?
Carolina Complete Health covers certain prescription drugs and over-the-counter drugs when prescribed by a Carolina Complete Health provider. The pharmacy program does not cover all drugs. Some drugs require prior authorization and may have limitations on age, dosage or maximum quantities.
Which Drugs are covered?
The Preferred Drug List (PDL) is a list of drugs covered by Carolina Complete Health. Carolina Complete Health works with the State of North Carolina to ensure that medications used to treat a variety of conditions and diseases are covered. The Preferred Drug List includes drugs you receive at retail pharmacies. Carolina Complete Health adheres to the NC Medicaid Preferred Drug List.
- The Preferred Drug List (PDL) allows NC Medicaid to obtain better prices for covered outpatient drugs through supplemental rebates. The PDL was authorized by the NC General Assembly Session Law 2009-451, Sections 10.66(a)-(d).
- Prescribers are encouraged to write prescriptions for “preferred” products.
- Prescribers may continue to write prescriptions for drugs not on the PDL.
- If a prescriber deems that the patient’s clinical status necessitates therapy with a non-preferred drug, the prescriber will be responsible for initiating a prior authorization request.
- Prior authorization requirements may be added to additional drugs in the future.
- Submit Proposed Clinical Policy Changes to the PDL
- Preferred Drug List Review Panel
Pharmacy Clinical Coverage Criteria
Pharmacy/Medication Pre-Authorization
- The Physician Administered Drug Program (PDP) covers certain primarily injectable drugs or biologic agents that are purchased and administered by a medical professional in office or in an outpatient clinic setting.
- The PDP catalog has a comprehensive list of covered drugs or biologic agents, with approved indications and restrictions.
- PDP requests can be submitted for off-label use. Such requests should contain information on the intended use of the drug.
For the Physican Administered Drug Program (PDP), please click here.
How to Submit PDP Requests
Details
- The Home Infusion Therapy (HIT) program covers self-administered infusion therapy, including IV chemotherapy and IV antibiotics through the outpatient pharmacy benefit.
- Please use the formulary search tool OR refer to the Preferred Drug List (PDL) for coverage details.
- Please see below for specific drug prior authorization request forms. In the absence of a specific form please use the Standard Request Form for prior authorization requests.
Disclaimer
For medical services, procedures and durable medical equipment please refer to the Medicaid Pre-Auth Tool.
How to Submit Home Infusion Therapy (HIT) Medication Requests
- Cover My Meds Portal
- Fax
1-866-399-0929 - PA Prescriber Help Desk (EPS)
1-833-585-4309
Details
- The outpatient pharmacy benefit includes a comprehensive list of prescription drugs, plus certain select OTC products.
- Please use EPS PA tool OR refer to the Preferred Drug List (PDL)/Clinical Coverage Policy 9A, Over-The-Counter Products (OTC) for coverage details.
- Please see below for specific drug prior authorization request forms. In the absence of a specific form please use the Standard Request Form for prior authorization requests.
Disclaimer
For medical services, procedures and durable medical equipment please refer to the Medicaid Pre-Auth Tool.
How to Submit Outpatient Pharmacy Requests
- Cover My Meds Portal
- Fax
1-866-399-0929 - PA Prescriber Help Desk (EPS)
1-833-585-4309
Pharmacy Prior authorizations can be submitted in 3 ways:
- Cover My Meds Portal
- Fax
1-866-399-0929 - PA Prescriber Help Desk (EPS)
1-833-585-4309
Prior Approval Request Forms
- Standard Drug Request Form (PDF)
- Adult Safety with Antipsychotic Prescribing (ASAP) Beneficiaries 18 Years of Age or Older (PDF)
- Antinarcolepsy Prior Approval Request Forms
- Antiparkinson's Agents: Gocovri and Osmolex (PDF)
- Antiparkinson's Agents: Inbrija and Ongentys (PDF)
- Antipsychotics - Keeping it Documented for Safety (A+KIDS) for Safety Beneficiaries 17 Years of Age and Younger (PDF)
- Austedo (PDF)
- Botox/Dysport/Myyobloc (PDF)
- Cialis (PDF)
- Continuous Glucose Monitors (PDF)
- Crinone 8% Gel (PDF)
- Cystic Fibrosis Medications (PDF)
- Dupixent - Asthma (PDF)
- Dupixent for Atopic Dermatitis (PDF)
- Dupixent for Nasal Polyps (PDF)
- Emend/Aprepitant (PDF)
- Emflaza (PDF)
- Epidiolex (PDF)
- Epinephrine Pens (PDF)
- Evrysdi (PDF)
- Exondys 51 (PDF)
- Fasenra (PDF)
- Gattex (PDF)
- Growth Hormone - Adult 21 Years of Age and Older (PDF)
- Growth Hormone - Children Less than 21 Years of Age (PDF)
- Hepatitis C Request Forms
- Hetlioz and Hetlioz LQ (PDF)
- Hyperimmunoglobulin D Syndrome (HIDS)/Mevalonate Kinase Deficiency (MKD) - (ILARIS) (PDF)
- Immunomodulators Request Forms
- Anklosing Spondylitis (PDF)
- Behcet's Disease (Otezla) (PDF)
- Crohn's Disease (Adult) (PDF)
- Crohn's Disease (Pediatric) (PDF)
- Cryopyrin-Associated Periodic Syndromes including Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS) (Arcalyst and Ilaris) (PDF)
- Cytokine Release Syndrome (Actemra and Actemra SQ) (PDF)
- Deficiency of Interleukin-1 Receptor Antagonist (DIRA) (Arcalyst and Kineret) (PDF)
- Familial Mediterranean Fever (FMF) (PDF)
- Giant Cell Arteritis (Actemra and Actemra SQ) (PDF)
- Hidradenitis Suppurativa (Humira) (PDF)
- Neonatal Onset: Multi-System Infammatory Disease (Kineret) (PDF)
- Neuromyelitis Optica Spectrum Disorder (NMOSD) (Uplizna and Enspryng) (PDF)
- Non-Infectious Intermediate Posterior Panuveitis (PDF)
- Non-Radiographic Axial Spondyloarthritis (Cimzia, Cosentyx and Taltz) (PDF)
- Plaque Psoriasis (Adult) (PDF)
- Plaque Psoriasis (Pediatric) (PDF)
- Polyarticular Juvenile Idiopathic Arthritis (Enbrel, Humira, Actemra SQ, Actemra Infusion, Orencia Infusion and Orencia SQ) (PDF)
- Psoriatic Arthritis (PDF)
- Rheumatoid Arthritis (Enbrel, Humira, Actemra Infusion, Actemra SQ, Cimzia, Inflectra, Kevzara, Kineret, Olumiant, Orencia Infusion, Orencia SQ, Remicade, Renflexis, Rinvoq ER, Simponi, Simponi Aria, Xeljanz and Xeljanz XR (PDF)
- Still's Disease - Adult Onset (Ilaris) (PDF)
- Systemic Onset Juvenile Idiopathic Arthritis (For Actemra SQ, Actemra Infusion and Ilaris) (PDF)
- Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS) (PDF)
- Ulcerative Colitis (Adult) (PDF)
- Ulcerative Colitis (Pediatric) (PDF)
- Ingrezza (PDF)
- Juxtapid or Kynamro (PDF)
- Topical Local Anesthetics (PDF)
- Lupus Medication - Benlysta (PDF)
- Lupus Medication - Lupkynis (PDF)
- Migraine Calcitonin Agents: Aimovig/Ajovy/Emgality/Vyepti (PDF)
- Migraine Calcitonin Gene Related Therapy (PDF)
- Monoclonal Antibody Therapy - Nucala (PDF)
- Monoclonal Antibody Therapy - Xolair (PDF)
- Monoclonal Antibodies: Xolair Nasal Polyps (PDF)
- Movement Disorders: Xenazine and Tetrabenazine (PDF)
- Neonatal Onset: Multi-System Inflammatory Disease - (Kineret) (PDF)
- Non-Covered State Medicaid Plan Services Request Form for Recipients under 21 Years Old (PDF)
- Opioid Analgesic, Long-Acting (PDF)
- Opioid Analgesic, Short-Acting (PDF)
- Opioid Dependence Therapy Agents (PDF)
- Palivizumab (Synagis) (PDF)
- PCSK9 Inhibitors (PDF)
- Procrit/Epogen/Aranesp (PDF)
- Sedative Hypnotics (PDF)
- Selective Constipation Agents (Relistor) (PDF)
- Stromectol (Ivermectin) Tablets (PDF)
- Topical Antihistamines (PDF)
- Topical Anti-Inflamatory Medications (PDF)
- Triptans (PDF)
- Vusion (PDF)
- Zolgensma (PDF)